GDTC logo

CytoMed Therapeutics Limited (GDTC) Depreciation And Amortization

Annual D&A

$283.80 K
-$1300.00-0.46%

31 December 2023

GDTC Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GDTC Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-0.5%--
3 y3 years+33.7%--
5 y5 years---

GDTC Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-0.5%+33.7%
5 y5 years-0.5%+33.7%
alltimeall time-0.5%+33.7%

CytoMed Therapeutics Limited Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2023
$283.80 K(-0.5%)
-
-
Dec 2022
$285.10 K(+16.1%)
-
-
DateAnnualQuarterlyTTM
Dec 2021
$245.50 K(+15.7%)
-
-
Dec 2020
$212.20 K
-
-

FAQ

  • What is CytoMed Therapeutics Limited annual depreciation & amortization?
  • What is the all time high annual D&A for CytoMed Therapeutics Limited?
  • What is CytoMed Therapeutics Limited annual D&A year-on-year change?

What is CytoMed Therapeutics Limited annual depreciation & amortization?

The current annual D&A of GDTC is $283.80 K

What is the all time high annual D&A for CytoMed Therapeutics Limited?

CytoMed Therapeutics Limited all-time high annual depreciation & amortization is $285.10 K

What is CytoMed Therapeutics Limited annual D&A year-on-year change?

Over the past year, GDTC annual depreciation & amortization has changed by -$1300.00 (-0.46%)